News | March 05, 2007

FDA Committee: Medtronic’s Chronicle Not Ready for Market

March 6, 2007 — Federal health advisors recommended in a 9-2 vote that the FDA not approve the Chronicle Implantable Hemodynamic Monitor from Medtronic, a device intended to detect worsening heart failure. A study of the device by the manufacturer suggested it is not effective.

FDA is not required to follow its advisory committees’ advice but does so most of the time.

The device functions by taking heart rate, temperature, pressure and patient activity measurements. The data can be downloaded by doctors in the office or securely transmitted to the Web for viewing.

Medtronic is studying a defibrillator that incorporates the monitoring technology.

"We continue to believe in the benefit of this sound technology and intend to work in close collaboration with the FDA to define the appropriate path for approval," said Dr. David M. Steinhaus, vice president and medical director of Medtronic’s cardiac rhythm disease management.


Related Content

Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
tandemLife Tandemheart priming tray cleared by FDA
Technology | Hemodynamic Support Devices| June 12, 2017
June 12, 2017 — TandemLife began its commercial launch of the TandemLife Priming Tray, a new product designed to simp
Sponsored Content | Videos | ACC| April 15, 2016
MDbuyline clinical analyst Tom Watson, BS, RCVT, explains the new hemodynamic system technology trends at ACC.16.
Siemens, Sensis Vibe hemodynamic system, ACC 2016
Technology | Hemodynamic Monitoring Systems| April 01, 2016
Siemens will unveil a revamped version of its established Sensis hemodynamic system at the 65 th Annual Scientific...
IBM Watson, Merge Healthcare, Best in KLAS 2015/2016, Phytel

Merge Hemo image courtesy of Merge Healthcare

News | Cardiac PACS| January 29, 2016
IBM Watson Health announced that the 2015/2016 Best in KLAS: Software & Services report recognized two of its newly...
The McKesson Cardiology CVIS integrates easily with either the McKesson (Change Healthcare) hemodynamics system or other vendors' systems
Feature | Cardiac PACS| September 11, 2015 | Dave Fornell
Two key requirements for today’s cardiovas...
Merge Healthcare, Toshiba, partner, cardiology, hemodynamic, vascular X-ray
Technology | June 30, 2015
Merge Healthcare Inc. announced that it has entered into a strategic partnership with Toshiba America Medical Systems,...
Cheetah Medical, Starling SV, hemodynamic monitoring system, noninvasive
Technology | June 26, 2015
Cheetah Medical announced that it is now offering the U.S. Food and Drug Administration (FDA)-cleared and CE-marked...
Thoratec, HeartMate II, ROADMAP
News | May 04, 2015
Thoratec Corp. announced results from the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left...
Merge Healthcare, Merge Cardio, Merge Hemo, Best in KLAS, 2014, PACS

Merge Hemo image courtesy of Merge Healthcare Inc.

News | January 29, 2015
Merge Healthcare Inc. announced that Merge Cardio has been named Best in KLAS for the cardiology software category in...
Overlay Init